Congress has given you clear direction and funding to invest in multiple routes to mass production, for multiple, plausible vaccine candidates in advance of their testing and approval, with the acknowledgement that much of that capacity will likely go unused when the final set of vaccines is chosen for mass deployment.
Foster emphasizes Congress's proactive role in vaccine production funding and strategy.
Share
More from Bill Foster
Frankly, when I read about this, it triggered my PTSD from the AIG situation with credit default swaps during the financial crisis.
I missed a recorded vote today. Had I been present, on Roll Call No. 227, Ogles Amendment No. 1 to H.R. 5403, CBDC Anti-Surveillance State Act, I would have voted `no'.
There are some complex issues here, but we are working constructively to get this done.
Other voices in this conversation
